# Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

> **NCT04386915** · PHASE1 · UNKNOWN · sponsor: **Fujian Cosunter Pharmaceutical Co. Ltd** · enrollment: 104 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** GST-HG141 tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04386915
- **Lead sponsor:** Fujian Cosunter Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-18
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-08-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386915, "Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04386915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*